Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 74.425B	--
Feb 12, 2025	2025/Q3	85.193B / 85.493B	--
Nov 11, 2024	2025/Q2	-- / 78.587B	--
Aug 13, 2024	2025/Q1	75.888B / 72.167B	--
May 13, 2024	2024/Q4	73.936B / 68.873B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 74.425B--

Feb 12, 20252025/Q385.193B / 85.493B--

Nov 11, 20242025/Q2-- / 78.587B--

Aug 13, 20242025/Q175.888B / 72.167B--

May 13, 20242024/Q473.936B / 68.873B--

Unlock Free Earnings Estimates

Open Account

Citizen Watch Earnings Reports

Citizen Watch: Summary of Financial Results for the 3rd Quarter Ending March 31, 2025 [Japanese GAAP] (Consolidated)

Feb 12 01:30 ET

Citizen Watch: Confirmation letter

Nov 11, 2024 01:58 ET

Citizen Watch: Half Year Report - Term 140 (2024/04/01 - 2025/03/31)

Nov 11, 2024 01:53 ET

Citizen Watch: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (Consolidated)

Nov 11, 2024 01:30 ET

Symbol Price % Chg

D. Western Therapeutics Institute